Dieser Beitrag beschäftigt sich systematisch mit dem Komplex der Rationalisierung medizinischer Leistungen. Als Ergebnis ergibt sich, daß explizite Rationierung der impliziten vorzuziehen ist und die Rationierungen möglichst ex ante auf der Makro-Ebene erfolgen sollten, ohne Gefährdung...

Dieser Beitrag beschäftigt sich systematisch mit dem Komplex der Rationalisierung medizinischer Leistungen. Als Ergebnis ergibt sich, daß explizite Rationierung der impliziten vorzuziehen ist und die Rationierungen möglichst ex ante auf der Makro-Ebene erfolgen sollten, ohne Gefährdung...

This analysis provides important insights about patient’s attitudes and understanding of benefits of breast cancer prevention and highlights the importance of the availability of an organised screening programme for screening differences across European countries. </AbstractSection> Copyright Springer-Verlag...

Caution must be taken when trying to transfer conclusions of pharmacoeconomics studies on migraines even in neighbouring countries. This cross-country variability is a concern for decision-makers and also for the elaboration of international recommendations and clinical practice guidelines. </AbstractSection>...

The past 23 years of post-socialist restructuring of health system funding and management patterns has brought many changes to small Balkan markets, putting them under increasing pressure to keep pace with advancing globalization. Socioeconomic inequalities in healthcare access are still...

The per-patient cost of epilepsy is substantial. Thus, even though the prevalence of the illness is relatively small, the aggregated cost that epilepsy incurs on society is significant. </AbstractSection> Copyright Springer-Verlag 2012

Previous research on male subjects has conjectured that subjective self-reports of health status may lead to an upward bias in the estimated effect of health on labor force participation because subjects who are out of the labor force may be more likely to understate their health status so as to...

The EORTC-C30 and EORTC-LC13 are the most frequently used health-related quality of life measurement instruments in pharmacological lung cancer trials. </AbstractSection> Copyright Damm et al.; licensee Springer. 2013